Molecular Nanotechnology Has Been Successful When Properly Funded

In January, 2022, – The first molecular electronics chip was developed. This achieved a 50-year-old goal of integrating single molecules into circuits to achieve the ultimate scaling limits of Moore’s Law. Developed by Roswell Biotechnologies and a multi-disciplinary team of leading academic scientists, the chip uses single molecules as universal sensor elements in a circuit …

Read more

DNA, RNA Reading Just Got Thousands of Times Faster

DNA, RNA and protein reading just got thousands of times faster with the commercial release of Roswell Biotechnologies molecular electronics chip. The first molecular electronics chip has been developed. This is realizing a 50-year-old goal molecular nanotechnology to integrate single molecules into circuits to achieve the ultimate scaling limits of Moore’s Law. It was developed …

Read more

Self-healing Fabric

A DNA construct is an artificially constructed segment of nucleic acid. It can be isolated or integrated in another DNA molecule. A recombinant DNA construct is produced by laboratory methods. Polynucleotide constructs with at least one disruption or tearing responsive promoter and at least one sequence encoding a fiber-forming protein. A cell with such constructs …

Read more

Moderna Coronavirus Vaccine Samples Shipped

Moderna shipped the first samples of messenger RNA based coronavirus vaccine to the National Institute of Allergy and Infectious Disease in Bethesda Maryland. Human clinical trials should start in 6 weeks and the results could be available in July. The Moderna vaccine will need two doses but is considered to be safe. Moderna messenger RNA …

Read more

Messenger RNA Treatment of Viruses Like Coronavirus

There has been 20 years of work on messenger RNA treatments against viruses. Technological advancements in RNA biology, chemistry, stability, and delivery systems have accelerated the development of fully synthetic mRNA vaccines. Molecular Therapy Journal (April 2019) reviewed mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases Vaccines – Enlisting the mRNA …

Read more

DARPA Nucleic Technology Funded to Get Virus Response to 1-60 Days

DARPA launched the Pandemic Prevention Platform program (P3) to stop pandemic treatments within 60 days of detection. The P3 program, which began in 2017, seeks to halt the spread of any infectious disease outbreak before it can escalate into a pandemic. The P3 teams are developing technologies to deliver antibodies using nucleic acid technology, and …

Read more

2020 Emergency Coronovirus Treatment Will Start in 3 Months Versus 2 Years for SARS in 2003

In 2003 it took 20 Months for the first experimental treatment for newly identified virus but in 2020 it appears it will take 3 months for the first treatments against the Wuhan Coronavirus. China has already published the genome sequence of the Wuhan Coronavirus and experimental vaccines should be in human testing by April, 2020. …

Read more

Electric Signal Detection from Single Molecules for Molecular Electronics Revolution

The barrier to molecular electronics was the previous inability to detect the tiny electric signals from single molecules. Roswell Biotechnologies overcame that problem and integrated the solution with CMOS. This enables an interface between molecules for sensors and DNA and other biological detections with CMOS. Nanopores have existed for a long time and being able …

Read more

What is hot in multi-billion dollar RNAi, Gene therapy and CAR-T biotech?

There were two biotech buyouts this week. Celgene bought CAR-T player Juno Therapeutics for $9 billion and Sanofi buying blood disorder biotech Bioverativ for $11 billion. Kite Pharmaceuticals, CAR-T company, got acquired late in 2017 by Gilead for $12 billion. Both Juno and Kite had been billed as CAR-T platform play. CAR-T acquisitions provide near-term …

Read more

RNA editing with CRISPR-Cas13

New Broad Institute ‘REPAIR’ system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome. The Broad Institute and MIT scientists who first harnessed CRISPR for mammalian genome editing have engineered a new molecular system for efficiently editing RNA in human cells. RNA editing, which can alter gene products without …

Read more